ARCHIVE

• LDP to Call For Enhancement of Int'l Competitiveness of Pharma Industry
  June 13, 2005

• Novartis to Acquire Hexal AG
  June 13, 2005

• Committee Recommends Import Approval for Kissei's Salagen
  June 13, 2005

• Pfizer Qualitatively and Quantitatively Beefs Up Its Marketing
  June 13, 2005

• Council Listens to Industry's Views on How to Strengthen Domestic Industry's Int'l Competitiveness
  June 13, 2005

• FY2005 to Be "Milepost" for Teijin Pharm: Mr Ohyagi
  June 13, 2005

• PMDA's Activities in FY2004 Wrapped Up
  June 13, 2005

• HEALTH FOOD/OTC NEWS IN BRIEF
  June 13, 2005

• STATISTICS
  June 13, 2005

• MEDICAL DEVICE NEWS IN BRIEF
  June 13, 2005

• JMED Approves FY2005 Business Plan
  June 13, 2005

• R&D NEWS IN BRIEF
  June 13, 2005

• Peg-IFN + Ribavirin to Become the Mainstay for Genotype 1 HCV with High Viral Load: Expert
  June 13, 2005

• JHSF Technology Transfer Center to Conclude 1st Patent License Agreement
  June 13, 2005

• Aromasin's Impact on Bone Metabolism is Temporary: Pfizer
  June 13, 2005

• Predicting Japan Pharma in 2010: Pharma Delegate Seminar
  June 6, 2005

• The Reporter's Eye: 9
  June 6, 2005

• CMIC: Strong Growth in Semiannual Sales, Profits
  June 6, 2005

• Toho Pharm.: Profits Plunge Despite 13.3% Rise in Sales
  June 6, 2005

• Wyeth's Gemtuzumab Recommended for Approval
  June 6, 2005

ページ

• « 先頭
• ‹ Prev
• …
• 461
• 462
• 463
• 464
• 465
• 466
• 467
• 468
• 469
• …
• Next ›
• 最終 »